miR-221 Suppression Through Nanoparticle-Based miRNA Delivery System for Hepatocellular Carcinoma Therapy and Its Diagnosis as a Potential Biomarker [Corrigendum]
Li F, Wang F, Zhu C, Wei Q, Zhang T, Zhou YL. Int J Nanomedicine. 2018;13:2295–2307. The authors have advised Figure 2B on page 2301 is incorrect. Due to an error at the time of figure assembly B1 and B2 were duplicated. The correct Figure 2 is shown bel...
Guardado en:
Autores principales: | Li F, Wang F, Zhu C, Wei Q, Zhang T, Zhou YL |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/285b634ed73b48069d0fb1ac8ea69293 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
miR-221 suppression through nanoparticle-based miRNA delivery system for hepatocellular carcinoma therapy and its diagnosis as a potential biomarker
por: Li F, et al.
Publicado: (2018) -
Suppression of miR-221 inhibits glioma cells proliferation and invasion via targeting SEMA3B
por: Cai,Guilan, et al.
Publicado: (2015) -
Circ_0091579 enhances the malignancy of hepatocellular carcinoma via miR-1287/PDK2 axis
por: Shu Junwei, et al.
Publicado: (2021) -
Aptamer-functionalized peptide H3CR5C as a novel nanovehicle for codelivery of fasudil and miRNA-195 targeting hepatocellular carcinoma
por: Liu Y, et al.
Publicado: (2016) -
LINC00839/miR-144-3p/WTAP (WT1 Associated protein) axis is involved in regulating hepatocellular carcinoma progression
por: Xingqin Zhou, et al.
Publicado: (2021)